Updates

Diabetes and Endocrinology

Programs and Services

Programs


The Texas Children’s Diabetes and Endocrinology Care Center works to provide comprehensive care for our patients with diabetes. Through our Community Diabetes Care outreach efforts, we create, sponsor and host community events that reach families beyond the clinic walls and let us build more meaningful relationships with them.

The Cystic Fibrosis-related Diabetes and Endocrine Disorders Clinic at Texas Children’s Hospital provides care for children with cystic fibrosis (CF) and diabetes or other endocrine problems.

Our multidisciplinary team manages disorders of sexual development within an ethical framework and educates parents to assist them in making informed decisions.

The Genetic Disorders of Obesity Program (GDOP) was created to help provide answers to families who have children who have struggled with weight gain from a very early age (prior to 5 years of age).  For some of these children, their weight struggles may be due to changes in their genetic code (the DNA code that informs the body how to develop and function).

The Texas Children's Diabetes and Endocrine Care Center enjoys caring for teens with diabetes and endocrine conditions. In the future, teens will move from our pediatric center to an adult diabetes or endocrine doctor.

At the Monogenic Diabetes Center at Texas Children’s Hospital and Baylor College of Medicine, cutting-edge medical care meets compassionate expertise for children suspected to have or diagnosed with monogenic diabetes.

Screening and Intervention to Delay Type 1 Diabetes (T1D) is available via our telemedicine-based program called SIT Down T1D! The program is for children and adolescents under the age of 18 who are at risk for developing type 1 diabetes. These individuals usually have a family member with T1D, who, in most cases, will be a sibling.

Our program offers a comprehensive primary care approach to address the myriad of needs in pediatric prediabetes. More information about the Texas Children’s Hospital Primary Care Practice at Palm Center can be found here.

For Referring Providers

If you require additional support in managing and monitoring prediabetes, we request that you refer your patient through this formalized program dedicated to the treatment of prediabetes in youth starting March 1, 2022.  

To refer patients to the Prediabetes Program at the TCH Primary Care Practice, simply place a referral order in EPIC or through our online referral form for prediabetes to the TCH Diabetes and Endocrinology practice.  The referral will be rerouted to the Prediabetes Program at the TCH Primary Care Practice.  More information about the Texas Children’s Hospital Primary Care Practice at Palm Center can be found here.

Our endocrine services will continue to be available for patients with Type 2 diabetes mellitus, defined as:

a.       a fasting glucose > 126 mg/dL on two separate occasions with risk factors, or

b.       a hemoglobin A1c > 6.5% on two separate occasions with risk factors, or

c.       a 2-hour glucose of > 200 mg/dL upon oral glucose tolerance testing. 

For your reference, we have also included links to the following resources:

  • Prediabetes Algorithm - The algorithm for the management of prediabetes in children that will be utilized by the Prediabetes Program at the Texas Children’s Hospital Primary Care Practice at Palm Center can be found here.
  • Community Resources - A list of Weight Management Nutrition and Community Resources compiled by Texas Children’s Hospital can be found here.
  • Texas Children’s Hospital Obesity Programs - Texas Children’s has programs designed to support children and adolescents with obesity who do not meet criteria for prediabetes or type 2 diabetes.  Please visit the obesity referrals page to review available programs and referral criteria or reference the Obesity Evidence Based Guidelines developed by a multi-disciplinary team at Texas Children’s Hospital.  
  • National Guidelines - National guidelines for the management of pediatric obesity were jointly published by the European Society of Endocrinology and the Pediatric Endocrine Society and are provided for your reference.

If someone in your family has type 1 diabetes you may be at risk.

Type 1 Diabetes TrialNet is an international network of clinical centers and affiliates – including Texas Children’s Hospital – exploring ways to prevent, delay and reverse the progression of type 1 diabetes. In response to the Surgeon General's Report Healthy People 2000, TrialNet was established to address diabetes prevention as a national health objective. Through personal screening and monitoring processes, this network is committed to the study, prevention and early treatment of type 1 diabetes.

About TrialNet

TrialNet TrialNet works with people who have a family member with type 1 diabetes and may be at risk for developing the disease, but do not yet have diabetes or a previous history of treatment for the disease. Eligible participants are tested for diabetes-related autoantibodies in the blood, which may be detectable in the blood many years before diagnosis of type 1 diabetes. Since autoantibody status can change, especially in children with maturing immune systems, TrialNet offers screening annually throughout childhood and young adulthood. 

Individuals who test positive for these autoantibodies while participating in TrialNet’s study are offered additional testing to help further determine their risk of developing type 1 diabetes. TrialNet notifies persons with negative diabetes-related test results with a letter in the mail in 4 to 6 weeks of the screening. Of the participants that are screened, approximately 95% test negative.

If the test results are positive for one or more autoantibodies, the participant is notified via phone call from a member of TrialNet’s study team. For preventative purposes, TrialNet explains to the participant which autoantibodies were detected and what options are available. Participants can then opt to continue on to the monitoring portion of TrialNet’s study.

The monitoring portion includes a baseline monitoring visit at a TrialNet site to estimate the research participant’s level of risk of developing the chronic disease. Participants are followed-up semi-annually for progression into type 1 diabetes. TrialNet will work with each research participant to fit his or her individual risk level. All participants, regardless of screening results, will be part of a research program that may help other people at risk for type 1 diabetes.

Eligibility Criteria

  • Have a first-degree relative (parents, children, siblings) between the ages of 2 – 45 with type 1 diabetes
  • Have a second-degree relative (cousin, aunt/uncle, grandchildren) between the ages of 2 – 20 with type 1 diabetes

How to get screened?  

  • Visit https://www.trialnet.org/participate and answer a few questions to sign up.  
  • You can request a blood collection kit to send your home, or you can get blood collection done in a local laboratory (for example, Quest Diagnostics Laboratory).   
  • Get your results in 4-6 weeks

Learn about TrialNet type 1 diabetes screening

Renowned Services Offered in Austin

We address a comprehensive spectrum of conditions for both children and women. Explore our specialized services, providing access to top-tier medical experts and state-of-the-art facilities. We also offer ambulatory specialty clinic, primary care urgent care and emergency services at our North Austin Campus.